Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
Business20 hours agoWarning! These ASX 200 shares were just downgraded
-
Business13 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News10 hours agoAFL live updates: Gold Coast vs Essendon – blog, scores and stats
-
Noosa News9 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89